This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the iShares Semiconductor ETF (SOXX)?
by Zacks Equity Research
Sector ETF report for SOXX
Should You Invest in the SPDR S&P Semiconductor ETF (XSD)?
by Zacks Equity Research
Sector ETF report for XSD
Is SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XSD
4 Top-Performing Sector ETFs of Q4
by Sanghamitra Saha
The fourth quarter of 2021 has been marked with events like eruptions of Omicron variant of COVID-19, renewed lockdowns in several parts of globe, sky-high inflation in the United States and the start of Fed pretty-fast QE tapering.
Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SOXX
4 ETF Areas Near One-Year High With More Room for Growth
by Sanghamitra Saha
Wall Street has been hovering around a record high level due to earnings strength, the ebbing pandemic, the economic reopening and the associated economic growth.
Semiconductor ETFs Flying High on Slew of Q3 Earnings Beat
by Sweta Killa
A spate of earnings beat has been acting as an icing on the cake, injecting further optimism into the space.
Should You Invest in the VanEck Semiconductor ETF (SMH)?
by Zacks Equity Research
Sector ETF report for SMH
Should You Invest in the SPDR S&P Semiconductor ETF (XSD)?
by Zacks Equity Research
Sector ETF report for XSD
Should You Invest in the iShares Semiconductor ETF (SOXX)?
by Zacks Equity Research
Sector ETF report for SOXX
5 Top-Ranked ETFs That Outperformed the Market in October
by Sweta Jaiswal, FRM
Studying the October rally, we highlight some top-ranked ETFs that have outperformed the market in the last month.
Is SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XSD
5 Top-Ranked Chip ETFs to Gain on Ongoing Supply Crisis
by Sweta Jaiswal, FRM
The semiconductor industry continues to be strong amid the coronavirus crisis as increasing inclination toward digitization is driving demand for the semiconductor chips.
The Zacks Analyst Blog Highlights: FTXL, TDV, IGN, XSD, and SKYY
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FTXL, TDV, IGN, XSD, and SKYY
Buy the Dip in 5 Top-Ranked Tech ETFs
by Sanghamitra Saha
Tech sector has been under pressure in recent weeks on rising rate worries. But the current weakness seems to be fleeting. Investors can buy the dip to realize the long-term potential.
Should You Invest in the SPDR S&P Semiconductor ETF (XSD)?
by Zacks Equity Research
Sector ETF report for XSD
5 ETFs to Cash In On Record High U.S. Household Net Worth
by Sanghamitra Saha
The net worth of American households touched a fresh all-time high in the second quarter.
Here's Why Semiconductor ETFs Are Looking Attractive for Q4
by Sweta Jaiswal, FRM
The semiconductor industry continues to be strong amid the coronavirus crisis as increasing inclination toward digitization is driving demand for semiconductor chips.
The Zacks Analyst Blog Highlights: SOXX, SMH, XSD, PSI and FTXL
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SOXX, SMH, XSD, PSI and FTXL
Semiconductor ETFs Soaring to New Heights
by Sweta Killa
Semiconductor ETFs have been rallying this year and are hitting new peaks on several occasions.
Semiconductor ETF (XSD) Hits New 52-Week High
by Sweta Killa
This semiconductor ETF hits a new 52-week high. Are more gains in store for this ETF?
5 Top-Ranked ETFs That Outperformed in August
by Sweta Jaiswal, FRM
Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.
4 Chip ETFs You Should Not Ignore
by Neena Mishra
Semiconductor ETFs surged after blockbuster earnings.
Fearing a September Slump? Buy These 5 ETFs
by Sanghamitra Saha
September is historically the worst month of the year for stocks. But this September could be different with these stock picks.
6 Best ETF Areas of August
by Sanghamitra Saha
Optimism about corporate earnings, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine, some upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexes go higher in August.